Fourteen new human monoclonal antibodies are now available through a partnership with Trillium Diagnostics including human anti-hemoglobin F, which recognizes fetal hemoglobin molecules; CD163 markers for anti-inflammatory signal and disease research; and CD64 markers, which react with Fc gamma 1 receptors. Rounding out the line is a monoclonal for MNDA (myeloid nuclear differentiation antigen). All antibodies are available unconjugated or conjugated to a selection of fluorochromes.